Videos uploaded by user “MD Magazine”
Autoimmune Hepatitis: a Rare Condition With Serious Consequences
Autoimmune hepatitis has only been known in its current form for around 20 years meaning there is still much to be learned about the condition.
Views: 8817 MD Magazine
Extended Data On Lemtrada Shows More Good News
As more and more treatments are approved for patients with multiple sclerosis questions are being answered about their effectiveness long past their approval dates. This is true for many of the medications including lemtrada.
Views: 5550 MD Magazine
Rocky Mountain Spotted Fever a Deadly Disease with a Difficult Diagnosis
It may be named after the mountains in Colorado, but the condition has very little do with its namesake and is more flu-like and affects other parts of the country.
Views: 4156 MD Magazine
Distinguishing Parkinson's Disease from Essential Tremor
Full synopsis: http://www.hcplive.com/hcplive-tv/Distinguishing-Parkinsons-Disease-from-Essential-Tremor- Daniel Kantor, MD, explains how neurologists differentiate between Parkinson's disease (PD) and essential tremor in patients who present with visible tremor.
Views: 48688 MD Magazine
Hossein Ameri, MD: Will CRISPR Fix Retinitis Pigmentosa?
Ameri and researchers at the USC Roski Eye Institute are testing the novel gene editing technique's potential to cure a difficult-to-treat condition.
Views: 1476 MD Magazine
Turning White Fat Into Brown Fat
While many people think all fat is created equal, making the transition from "white fat" to "brown fat can help a patient lose weight under properly monitored conditions.
Views: 9754 MD Magazine
Osteoarthritis of the Knee: Hyaluronic Acid Injections
Richard Iorio, MD; Paul Lachiewicz, MD; Peter L. Salgo, MD; and Andrew Spitzer, MD, debate the use of hyaluronic acid injections for osteoarthritis of the knee, including the administration, efficacy, and adverse effect profile.
Views: 3182 MD Magazine
Managing Central Sleep Apnea With Advancements In Treatment of Obstructive Sleep Apnea
While less is known about treating patients with central sleep apnea the condition can be managed in many cases by treating the patient's heart failure. For obstructive sleep apnea there are different treatment options which have each shown various levels of efficacy.
Views: 4996 MD Magazine
Ocrelizumab Provides Potential Answer to Difficult Treatment Questions
With doctors unable to prescribe an effective treatment for patients with progressive multiple sclerosis, an unanswered question has lingered for many years. A potential answer to this difficult question could be closer to reality than ever before.
Views: 2259 MD Magazine
Michael Miller, MD: REDUCE-IT Trial
Michael Miller, MD, an investigator on the REDUCE-IT trial, shares about the study's goals, surprising results, and clinical implications.
Views: 1516 MD Magazine
When to Suspect Diarrhea is Symptom of a Clostridium Difficile Infection
Lawrence J. Brandt, MD; Erik Dubberke, MD; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, distinguish between small bowel and large bowel diarrhea in patients with Clostridium difficile and discuss common approaches for diagnosing and managing patients.
Views: 2912 MD Magazine
Metronidazole vs Vancomycin in Mild Clostridium Difficile Infections
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, discuss provider considerations when making decisions on how to treat patients with Clostridium difficile with the guideline-suggested agents, vancomycin and metronidazole.
Views: 1399 MD Magazine
Learning More About Hypersomnia
It may not have quite the attention of other sleep disorders like sleep apnea but Hypersomnia can still affect a person's life in a variety ofways.
Views: 2049 MD Magazine
Developing New Treatments For Fibrosis and Cirrhosis
In the effort to help the growing number of people with liver disease new medications are constantly being developed. This is true for a wide range of conditions including cirrhosis and fibrosis.
Views: 2985 MD Magazine
Cocaine Causes Unseen Damage to the Heart
When cocaine users seek medical attention at a hospital regularly used scans may miss some hidden damage done to the patient's heart. A new study looked at other areas that could help maintain their longterm health.
Views: 2800 MD Magazine
Finding the Right Diet to Help Patients Lose Weight
There are any number of diets aimed at helping people lose weight. A recent study looked at whether a fasting diet was the way to go for the best results.
Views: 837 MD Magazine
Tecfidera Continues To Show Positive Results For Multiple Sclerosis Patients
Tecfidera has been on the market for a few years to help treat relapsing remitting multiple sclerosis and through extended studies and watching the market positive results have been seen by patients using the oral treatment.
Views: 1318 MD Magazine
The Role of Ivabradine in Heart Failure Management
In this segment, Sheryl Chow, PharmD, BCPS; Akshay Desai, MD; Peter L. Salgo, MD; Scott Solomon, MD; and Orly Vardeny, PharmD, MS, review the mechanism of action for ivabradine and provide insight regarding the 2016 American College of Cardiology/American Heart Association/Heart Failure Society of America heart failure treatment guideline update.
Views: 2117 MD Magazine
Gut Microbiome And Its Role In Multiple Sclerosis
The guy microbiome is being studied across the healthcare spectrum as more is learned about this part of a person's anatomy. What it could mean for the treatment of multiple sclerosis has yet to be determined.
Views: 1016 MD Magazine
M. Amin Karami, PhD, discusses piezoelectric pacemakers at the AHA 2012 Scientific Sessions
Lead study author M. Amin Karami, PhD, professor in the Department of Aerospace Engineering at the University of Michigan in Ann Arbor, discusses study results presented at AHA 2012 that demonstrated the technical feasibility of using a piezoelectric energy-harvesting device to power a pacemaker, potentially showing the way to a batteryless future for implantable cardiac devices. The nonlinear piezoelectric device used in the study generated sufficient power from heart rates of 20-600 beats per minute to power a pacemaker. Karami said that development of this technology promises to decrease size and increase longevity and functionality of cardiac implanted electrical devices.
Views: 1288 MD Magazine
Taking a Closer Look at Lipodystrophy
Full Text: http://www.hcplive.com/peer-exchange/rare-disorders/Taking-a-Closer-Look-at-Lipodystrophy The panel begins the discussion about specific rare diseases by focusing on lipodystrophy, a condition that can result in the loss of body fat from different parts of a patient’s body. The panelists also discuss familial hypercholesterolemia and familial chylomicronemia syndrome.
Views: 2677 MD Magazine
Ocrelizumab Shows First Signs of Promise For Patients With Primary Progressive Multiple Sclerosis
Even as more medications are developed for relapsing remitting multiple sclerosis patients those with the primary progressive form have been left waiting for news on their condition. According to recent studies the first step in that process may soon be coming to the market.
Views: 2030 MD Magazine
Military Physician Assistants Similar to Civilian Counterparts
The role of the physician assistant has grown in various ways throughout the medical community in recent years. That is also the case in military medicine as PA's treat soliders, sailors, airmen, and Marines in a wide variety of roles throughout the ranks.
Views: 3487 MD Magazine
Fidaxomicin in the Treatment of Clostridium Difficile Infections
Erik Dubberke, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, compare the use of fidaxomicin against standard therapy options, such as vancomycin, for the treatment of Clostridium difficile, suggesting that fidaxomicin may reduce a patient’s risk of recurrence.
Views: 961 MD Magazine
Comparing Eliquis to Warfarin In Atrial Fibrillation Patients
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Views: 3944 MD Magazine
Dr. Mark Mellow on Fecal Microbiota Transplant Follow-Up
Mark Mellow, MD, medical director of the Integris Digestive Health Center in Oklahoma City, discusses a study in which he followed up with patients who underwent fecal microbiota transplants to treat recurrent Clostridium difficile infection. He found positive results nearly across the board. This video was recorded at the annual scientific meeting of the American College of Gastroenterology.
Views: 9498 MD Magazine
A Closer Look at CIDP Diagnosis
Sometimes symptoms of CIDP can closely resemble those of other conditions. In light of this it is important for doctors to take a closer look to ensure a proper diagnosis is made.
Views: 2390 MD Magazine
Stiolto Provides New Treatment Option For Patients With COPD
With the number of patients diagnosed with COPD continuing to grow new treatment options are also needed to help these patients maintain a sustainable quality of life.
Views: 3283 MD Magazine
Finding New Ways to Treat Hypogonadism
For men who have low or reduced testosterone there can be many reasons for the cause of the condition and can require a variety of treatment methods. A study looked at a new way of delivering testosterone in pill form to help these patients.
Views: 1626 MD Magazine
Diagnosing Chronic Idiopathic Urticaria
People can experience bouts of urticaria over the course of their lives but usually they only last for a matter of days. When the symptoms last six weeks or more it can be classified as chronic idiopathic urticaria.
Views: 923 MD Magazine
New Data Support Benefit of Ocrevus for Relapsing, Primary Progressive Multiple Sclerosis
“We’re excited that the FDA approved Ocrevus for both relapsing MS patients and primary progressive MS patients just 4 weeks ago,” said Hideki Garren, MD, Group Medical Director, Genentech & Roche Pharmaceuticals at AAN 2017. The first approval for primary progressive MS patients who previously had no disease modifying treatment, ocrelizumab (Ocrevus), provides a new treatment for relapsing MS patients where there is a need for drugs that reduce disability progression. As an intravenous infusion, it’s only given once every 6 months, so patients only need to visit the doctor every six months for treatment.
Views: 1391 MD Magazine
Dr. Lawrence Brandt on Fecal Microbiota Transplant Part II
Lawrence Brandt, MD, professor of medicine and surgery at the Albert Einstein College of Medicine in New York City, discusses the safety of fecal transplant as well as its applications to conditions other than Clostridium difficile colitis. He explains that fecal transplant has an extremely high success rate (90+ percent) in a very short period of time, with no known adverse effects and relatively low cost. Other conditions the procedure may be used to treat include irritable bowel disease, constipation, bloating, ulcerative colitis, Parkinson's disease, myoclonic dystrophy, autism, and morbid obesity. This video was shot at the annual scientific conference of the American College of Gastroenterology.
Views: 4071 MD Magazine
Angiotensin Receptor Neprilysin Inhibition in Heart Failure
Sheryl Chow, PharmD, BCPS; Akshay Desai, MD; Peter L. Salgo, MD; Scott Solomon, MD, discuss the mechanism of action for angiotensin receptor neprilysin inhibition in the management of chronic heart failure and review the evidence with sacubitril/valsartan.
Views: 1048 MD Magazine
New Treatment Options for Optic Neuritis Shows 'Exciting' Results
As part of the overall picture of multiple sclerosis treatment optic neuritis is one of the early stages of the condition. The studies looked at sodium channels that show promise for future multiple sclerosis patients even if it is not in the field.
Views: 2789 MD Magazine
From Undocumented Immigrant to the Top of Cardiothoracic Surgery
Harold Fernandez, MD, was just 13 when he and his 11-year-old brother started the journey from a small town in Columbia to the United States. Despite arriving as an undocumented immigrant Fernandez worked his way through some of the best schools in the country to become a top doctor in his field.
Views: 856 MD Magazine
Tymlos Provides an Alternative Treatment for Women with Postmenopausal Menopause
At AACE 2017, John Bilezikian, MD, Professor of Medicine and Pharmacology at the College of Physicians & Surgeons, Columbia University, Chief, Emeritus, of the of the Division of Endocrinology and Director of the Metabolic Bone Diseases Program at Columbia University Medical Center discussed the latest FDA approval of Tymlos for postmenopausal women with osteoporosis and for women who are at high risk for fracture. “The development of this drug was very beautifully designed, and it turns out as the clinical trials were developed, that this drug proved itself, that it did do what we thought it would do.” Tymlos was found to markedly increase bone density in a very significant way and reduce fractures in postmenopausal women both at and outside the vertebral column.
Views: 1606 MD Magazine
The Role of Sacubitril/Valsartan in HFrEF
In this segment, Sheryl Chow, PharmD, BCPS; Peter L. Salgo, MD; Scott Solomon, MD; and Orly Vardeny, PharmD, MS, explain the role of sacubitril/valsartan in the management of chronic heart failure with reduced ejection fraction.
Views: 782 MD Magazine
Efficacy of Biologic Agents in Psoriatic Arthritis
Despite their effectiveness in treating psoriatic arthritis, biologic agents may carry a risk for infection. As a result, Allan Gibofsky, MD, discusses how rheumatologists manage patients being treated with a biologic agent.
Views: 491 MD Magazine
Manisha Madhoo, MD: What is Mydayis?
Mydayis was approved for the treatment of ADHD on June 20, 2017. Manisha Madhoo, MD, lets doctors know why they should add it to their treatment arsenal.
Views: 1277 MD Magazine
Barbara Phillips, MD: Sleep Apnea Diagnosis is Too Complicated
Sleep apnea is a common condition with an impact that goes beyond the affected patient. Diagnosis and treatment need to change to a more patient-centric model in order to improve outcomes.
Views: 955 MD Magazine
Studying Regression In Liver Disease
A considerable amount of research has been done looking at how liver disease can progress in patients, but a recent study looked at possible regression in conditions like cirrhosis and fibrosis.
Views: 1022 MD Magazine
Androgens and Estrogens and Their Effects on Men
Estrogen and its affect on women may be well known, but the impact it has on men is not quite as well established a recent study took a closer look on what it can mean for men's health.
Views: 2404 MD Magazine
Charles L Raison, MD: How Gut Microbiota Can Affect Mental Health
Charles L Raison, MD, explains the relationship between mental health and the trillions of microorganisms that live in and on our bodies.
Views: 376 MD Magazine
Taking the Next Steps in CIDP Treatment
As more is learned about the diagnosis and treatment of CIPD the medical community is also learning how best to work with patients with the condition.
Views: 1478 MD Magazine
Charles L Raison, MD: A History of Psychedelics in Psychiatry
Psychedelics like psilocybin have been receiving attention from psychiatrists on and off for decades. Here's where our understanding came from, and how it's evolved.
Views: 1391 MD Magazine
Aptiom Shows Strong Results as Epilepsy Monotherapy
With more than 2 million Americans affected by epilepsy, their course of treatment can affect not only how they handle the condition, but also their everyday quality of life. A recent study on an already approved medication may show more hope for the future.
Views: 632 MD Magazine
Zinbryta Looks To Bring New Tool to Multiple Sclerosis Treatent
While there are already several medications and treatments on the market for relapsing multiple sclerosis there continues to be a concerted effort to develop more in an effort to help as many patients as possible.
Views: 852 MD Magazine
Looking at the Future of HIV from Diagnosis to Cure
The treatment of HIV has improved by leaps and bounds since its first diagnosis but there is still much more work to be done.
Views: 1182 MD Magazine
Ingrezza for Tardive Dyskinesia: Its Safety, Efficacy, and Implication
Laxman Bahroo, DO, discusses the historic approval of valbenazine (Ingrezza) for Tardive Dyskinesia, and how it changes the landscape of the movement disorder's treatment.
Views: 1529 MD Magazine

12 mg zofran 4mg
Glyburide metformin 2 5 500mg tabse
Requip 2mg tablet side effects
Paroxetine 20 mg effects indesirables
Difosfato de chloroquine 250 mg onde comprar roupas